UChicago Medicine Comprehensive Cancer Center

Ovarian carcinosarcoma is a very rare cancer and accounts for about 1-4% of new ovarian cancer diagnoses. Historically, these cancers were thought to be related to a type of tumor called sarcoma, which grows out of stroma, or connective tissues. It can also form in the bones and soft tissues, but recent research suggests that ovarian carcinosarcoma is more similar to common (epithelial) ovarian cancers than initially thought.  

microscopic view of ovarian carcinosarcoma
A microscopic example of a carcinosarcoma tumor showing multiple components of the tumor, including both carcinomatous (such as glandular) and sarcomatous (spindle cells) elements.

Symptoms and Diagnosis

Many patients with this type of ovarian cancer will have a large, fast-growing ovarian mass and might experience symptoms such as: 

  • Bloating
  • Feeling full quickly 
  • Pain
  • Feeling a mass in the belly
  • Worsening tiredness (fatigue)

Often the diagnosis of ovarian carcinosarcoma is made only after surgery, based on the pathology report. UChicago Medicine specialized gynecologic pathologists can help ensure the correct diagnosis is made.

Initial Treatment

Ovarian carcinosarcoma is often managed with a combination of surgery and chemotherapy. Similar to other ovarian cancers, the treatment for ovarian carcinosarcoma often includes aggressive surgeries aimed to remove as much of the visible cancer as possible. Our team of gynecologic cancer surgeons have extensive experience caring for patients with this rare type of ovarian cancer. Chemotherapy is often needed in addition to surgery, and there may be opportunities for clinical trial participation. If the tumor is very extensive on CT imaging, we may choose to do chemotherapy first.

Treatment for Recurrent Ovarian Carcinosarcoma

Ovarian carcinosarcoma can be very difficult to treat once it returns. Chemotherapy is typically the mainstay of treatment, but in select patients, surgery is sometimes recommended as well. We often use chemotherapies similar to those used in more common types of ovarian cancer. As we learn more about ovarian carcinosarcoma we continue to identify new molecular characteristics which may help us find better treatment options. 

At the University of Chicago Medicine, we have a robust clinical trials program that constantly evaluates new targeted therapies, immunotherapies and combinations of treatments to improve the lives and outcomes of patients with ovarian carcinosarcoma. If indicated, we will also evaluate your family members in our cancer prevention clinic to help them understand if they are at a higher risk for developing cancer. Thanks to a recent research grant awarded to our gynecologic cancer research team, we are focusing our research efforts on this rare type of ovarian cancer to understand its biology and to find novel treatments.

 

Convenient Locations for Gynecologic Oncology Care

Request an Appointment

We are currently experiencing a high volume of inquiries, leading to delayed response times. For faster assistance, please call 1-855-702-8222 to schedule your appointment.

If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.

* Indicates required field

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.
S. Diane Yamada, MD, and Ernst Lengyel, MD, gynecologic oncologists

Cancer Care Second Opinions

Request a second opinion from UChicago Medicine experts in cancer care.

researcher in cancer lab

Participate in a Clinical Trial

UChicago Medicine ovarian cancer experts are actively conducting clinical trials of new and promising treatments.

Young black female patient talking with doctor or nurse

Gynecologic Cancer Prevention Clinic

Our cancer prevention experts provide comprehensive and personalized care for women at elevated risk for endometrial (uterine) cancer and ovarian cancer.